[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 80, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2025, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 78, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2025, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 65, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2025, "totalPay": 607500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 57, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2025, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 70, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 71, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.691, "open": 0.71, "dayLow": 0.6711, "dayHigh": 0.7185, "regularMarketPreviousClose": 0.691, "regularMarketOpen": 0.71, "regularMarketDayLow": 0.6711, "regularMarketDayHigh": 0.7185, "payoutRatio": 0.0, "beta": 1.524, "forwardPE": 0.25412187, "volume": 244892, "regularMarketVolume": 244892, "averageVolume": 863698, "averageVolume10days": 715060, "averageDailyVolume10Day": 715060, "bid": 0.6654, "ask": 0.7443, "bidSize": 1, "askSize": 1, "marketCap": 15864887, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 2.97, "allTimeHigh": 937.5, "allTimeLow": 0.63, "priceToSalesTrailing12Months": 4.022424, "fiftyDayAverage": 0.91324, "twoHundredDayAverage": 1.15862, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23482948, "profitMargins": 0.0, "floatShares": 21883474, "sharesOutstanding": 22376427, "sharesShort": 2719644, "sharesShortPriorMonth": 3166818, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.12149999, "heldPercentInsiders": 0.022030002, "heldPercentInstitutions": 0.07689, "shortRatio": 9.09, "shortPercentOfFloat": 0.1258, "impliedSharesOutstanding": 22376427, "bookValue": 3.573, "priceToBook": 0.19843268, "lastFiscalYearEnd": 1759190400, "nextFiscalYearEnd": 1790726400, "mostRecentQuarter": 1767139200, "netIncomeToCommon": -35886448, "trailingEps": -2.46, "forwardEps": 2.79, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToRevenue": 5.954, "enterpriseToEbitda": -0.646, "52WeekChange": -0.6902834, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 0.709, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 7721393, "totalCashPerShare": 0.345, "ebitda": -36357252, "totalDebt": 1829646, "quickRatio": 0.308, "currentRatio": 0.993, "totalRevenue": 3944111, "debtToEquity": 1.958, "revenuePerShare": 0.271, "returnOnAssets": -0.17681, "returnOnEquity": -0.47852, "grossProfits": 3154903, "freeCashflow": -40525064, "operatingCashflow": -34835708, "grossMargins": 0.7999, "ebitdaMargins": 0.0, "operatingMargins": -2.14136, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.60492, "regularMarketPrice": 0.709, "epsTrailingTwelveMonths": -2.46, "epsForward": 2.79, "epsCurrentYear": 1.66, "priceEpsCurrentYear": 0.42710844, "fiftyDayAverageChange": -0.20424002, "fiftyDayAverageChangePercent": -0.22364332, "twoHundredDayAverageChange": -0.44962, "twoHundredDayAverageChangePercent": -0.38806513, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771635064, "regularMarketTime": 1771621202, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": -1.9605052, "postMarketPrice": 0.6951, "postMarketChange": -0.013899982, "regularMarketChange": 0.018, "regularMarketDayRange": "0.6711 - 0.7185", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 863698, "fiftyTwoWeekLowChange": 0.078999996, "fiftyTwoWeekLowChangePercent": 0.12539682, "fiftyTwoWeekRange": "0.63 - 2.97", "fiftyTwoWeekHighChange": -2.2610002, "fiftyTwoWeekHighChangePercent": -0.7612795, "fiftyTwoWeekChangePercent": -69.02834, "dividendDate": 1496966400, "earningsTimestamp": 1770989400, "earningsTimestampStart": 1778851800, "earningsTimestampEnd": 1778851800, "isEarningsDateEstimate": true, "marketState": "CLOSED", "shortName": "Citius Pharmaceuticals, Inc.", "longName": "Citius Pharmaceuticals, Inc.", "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]